Viral causes of feline lymphoma: Retroviruses and beyond

Veterinary Journal

Volumn 201, Issue 2, 2014, Pages 174-180

  Beatty, Julia ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Feline; Leukaemia; Lymphoma; Retrovirus; Viral oncogenesis

Indexed keywords

CAT; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; DISEASE COURSE; EUKARYOTIC CELL; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HERPES VIRUS; IMMUNE RESPONSE; LEUKEMIA; LYMPHOMA; NONHUMAN; PATHOGENESIS; PREVALENCE; REMISSION; RETROVIRUS; REVIEW; VACCINATION; VIRUS CARCINOGENESIS; ANIMAL; CAT DISEASE; LENTIVIRUS INFECTION; PHYSIOLOGY; RETROVIRUS INFECTION; VETERINARY; VIROLOGY; VIRUS INFECTION;

EUKARYOTA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; GAMMARETROVIRUS; LENTIVIRUS;

ANIMALS; CAT DISEASES; CATS; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS INFECTIONS; LEUKEMIA VIRUS, FELINE; LYMPHOMA; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 84904734861     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.05.026     Document Type: Review

References (141)

1. Abujamra A.L., Faller D.V., Ghosh S.K. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication. Virology 2003, 309:294-305.
2. Abujamra A.L., Spanjaard R.A., Akinsheye I., Zhao X.S., Faller D.V., Ghosh S.K. Leukemia virus long terminal repeat activates NF kappa B pathway by a TLR3-dependent mechanism. Virology 2006, 345:390-403.
3. Ackley C.D., Yamamoto J., Levy N., Pedersen N., Cooper M. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. Journal of Virology 1990, 64:5652-5655.
4. Ali H., Donovan B., Wand H., Read T.R.H., Regan D.G., Grulich A.E., Fairley C.K., Guy R.J. Genital warts in young Australians five years into national human papillomavirus vaccination programme: National surveillance data. British Medical Journal 2013, 346.
5. Barrs V.R., Martin P., Nicoll R.G., Beatty J.A., Malik R. Pulmonary cryptococcosis and Capillaria aerophila infection in an FIV-positive cat. Australian Veterinary Journal 2000, 78:154-158.
6. Beatty J., Terry A., MacDonald J., Gault E., Cevario S., O'Brien S.J., Cameron E., Neil J.C. Feline immunodeficiency virus integration in B-cell lymphoma identifies a candidate tumor suppressor gene on human chromosome 15q15. Cancer Research 2002, 62:7175-7180.
7. Beatty J.A., Callanan J.J., Terry A., Jarrett O., Neil J.C. Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: A direct role for FIV in B-lymphocyte transformation?. Journal of Virology 1998, 72:767-771.
8. Beatty J.A., Lawrence C.E., Callanan J.J., Grant C.K., Gault E.A., Neil J.C., Jarrett O. Feline immunodeficiency virus (FIV)-associated lymphoma: A potential role for immune dysfunction in tumourigenesis. Veterinary Immunology and Immunopathology 1998, 65:309-322.
9. Beatty J.A., Tasker S., Jarrett O., Lam A., Gibson S., Noe-Nordberg A., Phillips A., Fawcett A., Barrs V.R. Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence. Journal of Feline Medicine and Surgery 2011, 13:927-933.
10. Beatty, J.A., Troyer, R.M., Brewster, C., Rovnak, R., Barrs, V.R., Quackenbush, S.L., VandeWoude, S., 2012. Feline immunodeficiency virus (FIV)-associated lymphoma. Is a gammaherpesvirus involved? In: 2nd International Society for Companion Animal Infectious Diseases symposium. ISCAID, San Francisco, CA, USA, p. 27 (Abstract 03).
11. Beatty J.A., Troyer R.M., Carver S., Barrs V.R., Espinasse F., Conradi O., Stutzman-Rodriguez K., Chan C., Tasker S., Lappin M.R., et al. Felis catus gammaherpesvirus 1: A widely endemic potential pathogen of domestic cats. Virology 2014, 460-461:100-107.
12. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Tozzini F. Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clinical Microbiology Reviews 1995, 8:87-112.
13. Bolin L.L., Levy L.S. Viral determinants of FeLV infection and pathogenesis: Lessons learned from analysis of a natural cohort. Viruses-Basel 2011, 3:1681-1698.
14. Bonham L., Lobellerich P.A., Henderson L.A., Levy L.S. Transforming potential of a myc-containingvariant of feline leukemia-virus invitro in early passage feline cells. Journal of Virology 1987, 61:3072-3081.
15. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., et al. A review of human carcinogens-Part B: biological agents. Lancet Oncology 2009, 10:321-322.
16. Brown D.R., Kjaer S.K., Sigurdsson K., Iversen O.-E., Hernandez-Avila M., Wheeler C.M., Perez G., Koutsky L.A., Tay E.H., Garcia P., et al. The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26years. Journal of Infectious Diseases 2009, 199:926-935.
17. Bruce A.G., Bielefeldt-Ohmann H., Barcy S., Bakke A.M., Lewis P., Tsai C.-C., Murnane R.D., Rose T.M. Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas. PLoS Pathogens 2012, 8:e1002962.
18. Burnet F.M. Concept of immunological surveillance. Progress in Experimental Tumor Research 1970, 13:1-27.
19. Callanan J.J., Jones B.A., Irvine J., Willett B.J., McCandlish I.A.P., Jarrett O. Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Veterinary Pathology 1996, 33:264-272.
20. Carbone A., Cesarman E., Spina M., Gloghini A., Schulz T.F. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009, 113:1213-1224.
21. Castro K.G., Ward J.W., Slutsker L., Buehler J.W., Jaffe H.W., Berkelman R.L., Curran J.W. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 1992, 41.
22. Cattori V., Pepin A.C., Tandon R., Riond B., Meli M.L., Willi B., Lutz H., Hofmann-Lehmann R. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets. Veterinary Immunology and Immunopathology 2008, 123:124-128.
23. Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Letters 2011, 305:163-174.
24. Cesarman E. Viral lymphomas: Can antivirals be used to treat cancer?. Hematology (Amsterdam, Netherlands) 2012, 17:S83-S86.
25. Chandhasin C., Lobelle-Rich P., Levy L.S. Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster. Journal of General Virology 2004, 85:2937-2942.
26. Chiou S.-H., Chow K.-C., Yang C.-H., Chiang S.-F., Lin C.-H. Discovery of Epstein-Barr virus (EBV)-encoded RNA signal and EBV nuclear antigen leader protein DNA sequence in pet dogs. Journal of General Virology 2005, 86:899-905.
27. Cohen J.I. Epstein-Barr virus infection. New England Journal of Medicine 2000, 343:481-492.
28. Cohen J.I., Fauci A.S., Varmus H., Nabel G.J. Epstein-Barr virus: An important vaccine target for cancer prevention. Science Translational Medicine 2011, 3:107fs107.
29. Cotter S.M., Hardy W.D., Essex M. Association of feline leukemia-virus with lymphosarcoma and other disorders in the cat. Journal of the American Veterinary Medical Association 1975, 166:449-454.
30. Court E.A., Watson A.D.J., Peaston A.E. Retrospective study of 60 cases of feline lymphosarcoma. Australian Veterinary Journal 1997, 75:424-427.
31. Dang C.V. c-myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and Cellular Biology 1999, 19:1-11.
32. Donahue P.R., Quackenbush S.L., Gallo M.V., Denoronha C.M.C., Overbaugh J., Hoover E.A., Mullins J.I. Viral genetic-determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia-virus FELV-FAIDS. Journal of Virology 1991, 65:4461-4469.
33. Dorn C.R., Taylor D.O.N., Schneider R., Hibbard H.H., Klauber M.R. Survey of animal neoplasms in Alameda and Contra Costa counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 1968, 40:307-318.
34. Du M.Q., Bacon C.M., Isaacson P.G. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. Journal of Clinical Pathology 2007, 60:1350-1357.
35. Endo Y., Cho K.-W., Nishigaki K., Momoi Y., Nishimura Y., Mizuno T., Goto Y., Watari T., Tsujimoto H., Hasegawa A. Molecular characteristics of malignant lymphomas in cats naturally infected with feline immunodeficiency virus. Veterinary Immunology and Immunopathology 1997, 57:153-167.
36. Endo Y., Cho K.W., Nishigaki K., Momoi Y., Nishimura Y., Mizuno T., Goto Y., Watari T., Tsujimoto H., Hasegawa A. Molecular characteristics of malignant lymphomas in cats naturally infected with feline immunodeficiency virus. Veterinary Immunology and Immunopathology 1997, 57:153-167.
37. Englert T., Lutz H., Sauter-Louis C., Hartmann K. Survey of the feline leukemia virus infection status of cats in Southern Germany. Journal of Feline Medicine and Surgery 2012, 14:392-398.
38. English R., Nelson P., Johnson C.M., Nasisse M., Tompkins W.A., Tompkins M.B. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. Journal of Infectious Diseases 1994, 170:543.
39. Feder B.M., Hurvitz A.I. Feline immunodeficiency virus infection in 100 cats and association with lymphoma. Journal of Veterinary Internal Medicine 1990, 4:110.
40. Flynn J., Cannon C., Lawrence C., Jarrett O. Polyclonal B-cell activation in cats infected with feline immunodeficiency virus. Immunology 1994, 81:626.
41. Francis D.P., Cotter S.M., Hardy W.D., Essex M. Comparison of virus-positive and virus-negative cases of feline leukemia and lymphoma. Cancer Research 1979, 39:3866-3870.
42. Francis D.P., Essex M., Cotter S.M., Gutensohn N., Jakowski R., Hardy W.D. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline-leukemia virus. Cancer Letters 1981, 12:37-42.
43. Fujino Y., Ohno K., Tsujimoto H. Molecular pathogenesis of feline leukemia virus-induced malignancies: Insertional mutagenesis. Veterinary Immunology and Immunopathology 2008, 123:138-143.
44. Fulton R., Forrest D., McFarlane R., Onions D., Neil J.C. Retroviral transduction of T-cell antigen receprtor b-chain and myc genes. Nature 1987, 326:190-194.
45. Fulton R., Plumb M., Shield L., Neil J.C. Structural diversity and nuclear-protein binding-sites on the long terminal repeats of feline leukaemia-virus. Journal of Virology 1990, 64:1675-1682.
46. Gabor L.J., Jackson M.L., Trask B., Malik R., Canfield P.J. Feline leukaemia virus status of Australian cats with lymphosarcoma. Australian Veterinary Journal 2001, 79:476-481.
47. Gabor L.J., Love D.N., Malik R., Canfield P.J. Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Australian Veterinary Journal 2001, 79:540-545.
48. Gleich S., Hartmann K. Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats. Journal of Veterinary Internal Medicine 2009, 23:552-558.
49. Gleich S.E., Krieger S., Hartmann K. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. Journal of Feline Medicine and Surgery 2009, 11:985-992.
50. Gomes-Keller M.A., Gonczi E., Tandon R., Riondato F., Hofmann-Lehmann R., Meli M.L., Lutz H. Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. Journal of Clinical Microbiology 2006, 44:916-922.
51. Grassmann R., Aboud M., Jeang K.-T. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985.
52. Hanlon L., Argyle D., Bain D., Nicolson L., Dunham S., Golder M.C., McDonald M., McGillivray C., Jarrett O., Neil J.C., et al. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. Journal of Virology 2001, 75:8424-8433.
53. Hardy W.D. The feline sarcoma-viruses. Journal of the American Animal Hospital Association 1981, 17:981-997.
54. Hardy W.D. Hematopoietic tumors of cats. Journal of the American Animal Hospital Association 1981, 17:921-940.
55. Hardy W.D. Immunopathology induced by the feline leukemia-virus. Springer Seminars in Immunopathology 1982, 5:75-106.
56. Hardy W.D., Hess P.W., MacEwen E.G., McClelland A.J., Zuckerman E.E., Essex M., Cotter S.M., Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Research 1976, 36:582-588.
57. Hardy W.D., McClelland A.J., Zuckerman E.E., Hess P.W., Essex M., Cotter S.M., Macewen E.G., Hayes A.A. Prevention of contagious spread of feline leukemia-virus and development of leukemia in pet cats. Nature 1976, 263:326-328.
58. Hardy W.D., McClelland A.J., Macewen E.G., Hess P.W., Hayes A.A., Zuckerman E.E. Epidemiology of feline leukemia-virus (FeLV). Cancer 1977, 39:1850-1855.
59. Hardy W.D., McClelland A.J., Zuckerman E.E., Snyder H.W., Macewen E.G., Francis D., Essex M. Development of virus non-producer lymphosarcoma in pet cats exposed to FeLV. Nature 1980, 288:90-92.
60. Helfer-Hungerbuehler A.K., Cattori V., Boretti F.S., Ossent P., Grest P., Reinacher M., Henrich M., Bauer E., Bauer-Pham K., Niederer E., et al. Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma. Retrovirology 2010, 7:14.
61. Herndier B.G., Shiramizu B.T., Jewett N.E., Aldape K.D., Reyes G.R., McGrath M.S. Acquired immunodeficiency syndrome-associated T-cell lymphoma- evidence for human-immunodeficiency-virus type-1-associated T-cell transformation. Blood 1992, 79:1768-1773.
62. Herring E.S., Troy G.C., Toth T.E., Forrester S.D., Weigt L.A., Herring I.P. Detection of feline leukaemia virus in blood and bone marrow of cats with varying suspicion of latent infection. Journal of Feline Medicine and Surgery 2001, 3:133-141.
63. Hoffmann-Fezer G., Thum J., Ackley C., Herbold M., Mysliwietz J., Thefeld S., Hartmann K., Kraft W. Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection. Journal of Virology 1992, 66:1484-1488.
64. Hofmann-Lehmann R., Huder J.B., Gruber S., Boretti F., Sigrist B., Lutz H. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. Journal of General Virology 2001, 82:1589-1596.
65. Hofmann-Lehmann R., Tandon R., Boretti F.S., Meli M.L., Willi B., Cattori V., Gomes-Keller M.A., Ossent P., Golder M.C., Flynn J.N., et al. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 2006, 24:1087-1094.
66. Hoover E.A., Mullins J.I. Feline leukemia virus infection and diseases. Journal of the American Veterinary Medical Association 1991, 199:1287-1297.
67. Hoover E.A., Perigo N.A., Quackenbush S.L., Mathiasondubard C.K., Overbaugh J.M., Kloetzer W.S., Elder J.H., Mullins J.I. Protection against feline leukemia-virus infection by use of an inactivated virus-vaccine. Journal of the American Veterinary Medical Association 1991, 199:1392-1401.
68. Hosie M., Robertson C., Jarrett O. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Veterinary Record 1989, 125:293-297.
69. Huang S.H., Kozak P.J., Kim J., Habineza-Ndikuyeze G., Meade C., Gaurnier-Hausser A., Patel R., Robertson E., Mason N.J. Evidence of an oncogenic gammaherpesvirus in domestic dogs. Virology 2012, 427:107-117.
70. Hutson C.A., Rideout B.A., Pedersen N.C. Neoplasia associated with feline immunodeficiency virus-infection of cats in Southern California. Journal of the American Veterinary Medical Association 1991, 199:1357-1362.
71. Jackson M.L., Haines D.M., Meric S.M., Misra V. Feline leukemia virus detection by immunohistochemistry and polymerase chain-reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Canadian Journal of Veterinary Research-Revue Canadienne de Recherche Veterinaire 1993, 57:269-276.
72. Jarrett O., Hardy W.D., Golder M.C., Hay D. The frequency of occurrence of feline leukaemia virus subgroups in cats. International Journal of Cancer 1978, 21:334-337.
73. Jarrett W.F.H., Davie F., Martin W.B., Crawford E.M. Virus-like particle associated with leukaemia (lymphosarcoma). Nature 1964, 202:567-569.
74. Levine A.M. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992, 80:8-20.
75. Levy, J., Lorentzen, L., Shields, J., Lewis, H., 2006a. Long-term outcome of cats with natural FeLV and FIV infection. In: Proceedings of the 8th International Feline Retrovirus Research Symposium, Washington DC, USA.
76. Levy J.K., Scott H.M., Lachtara J.L., Crawford P.C. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. Journal of the American Veterinary Medical Association 2006, 228:371-376.
77. Levy L.S., Fish R.E., Baskin G.B. Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats. Journal of Virology 1988, 62:4770-4773.
78. Levy L.S., Lobelle-Rich P.A., Overbaugh J. flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes bmi-1. Oncogene 1993, 8:1833-1838.
79. Levy L.S., Lobellerich P.A., Overbaugh J., Abkowitz J.L., Fulton R., Royburman P. Coincident involvement of flvi-2, c-myc and novel env genes in natural and experimental lymphosarcoma induced by feline leukemia virus. Virology 1993, 196:892-895.
80. Lewinski M.K., Yamashita M., Emerman M., Ciuffi A., Marshall H., Crawford G., Collins F., Shinn P., Leipzig J., Hannenhalli S., et al. Retroviral DNA integration: Viral and cellular determinants of target-site selection. PLoS Pathogens 2006, 2:e60.
81. Liem B.P., Dhand N.K., Pepper A.E., Barrs V.R., Beatty J.A. Clinical findings and survival in cats naturally infected with feline immunodeficiency virus. Journal of Veterinary Internal Medicine 2013, 27:798-805.
82. Louwerens M., London C.A., Pedersen N.C., Lyons L.A. Feline lymphoma in the post-feline leukemia virus era. Journal of Veterinary Internal Medicine 2005, 19:329-335.
83. Macsween K.F., Crawford D.H. Epstein-Barr virus - recent advances. The Lancet Infectious Diseases 2003, 3:131-140.
84. Magden E., Miller C., MacMillan M., Bielefeldt-Ohmann H., Avery A., Quackenbush S.L., VandeWoude S. Acute virulent infection with feline immunodeficiency virus (FIV) results in lymphomagenesis via an indirect mechanism. Virology 2012, Accepted 4 December 2012.
85. Magden E., Miller C., MacMillan M., Bielefeldt-Ohmann H., Avery A., Quackenbush S.L., VandeWoude S. Acute virulent infection with feline immunodeficiency virus (FIV) results in lymphomagenesis via an indirect mechanism. Virology 2013, 436:284-294.
86. Major A., Cattori V., Boenzli E., Riond B., Ossent P., Meli M.L., Hofmann-Lehmann R., Lutz H. Exposure of cats to low doses of FeLV: Seroconversion as the sole parameter of infection. Veterinary Research 2010, 41.
87. McClelland A.J., Hardy W.D., Zuckerman E.E. Prognosis of healthy feline leukemia virus infected cats. Feline Leukemia Virus 1980, vol. 4:121-126. Elsevier, North Holland.
88. Meichner K., Kruse B.D., Hirschberger J., Hartmann K. Changes in prevalence of progressive feline leukaemia virus infection in cats with lymphoma in Germany. Veterinary Record 2012, 171:348.
89. Milman G., Smith K.C., Erles K. Serological detection of Epstein-Barr virus infection in dogs and cats. Veterinary Microbiology 2011, 150:15-20.
90. Mitchell R.S., Beitzel B.F., Schroder A.R., Shinn P., Chen H., Berry C.C., Ecker J.R., Bushman F.D. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biology 2004, 2:e234.
91. Modlich U., Baum C. Preventing and exploiting the oncogenic potential of integrating gene vectors. The Journal of Clinical Investigation 2009, 119:755-758.
92. Munday J.S., Dunowska M., Hills S.F., Laurie R.E. Genomic characterization of Felis catus papillomavirus-3: A novel papillomavirus detected in a feline Bowenoid in situ carcinoma. Veterinary Microbiology 2013, 165:319-325.
93. Neil J., Fulton R., Rigby M., Stewart M. Feline leukaemia virus: Generation of pathogenic and oncogenic variants. Retroviral Insertion and Oncogene Activation 1991, 67-93. Springer.
94. Olsen R., Lewis M., Lafrado L., Mathes L., Haffer K., Sharpee R. Feline leukemia virus: Current status of the feline induced immune depression and immunoprevention. Cancer and Metastasis Reviews 1987, 6:243-260.
95. Onions D., Lees G., Forrest D., Neil J. Recombinant feline viruses containing the myc gene rapidly produce clonal tumors expressing T-cell antigen receptor gene transcripts. International Journal of Cancer 1987, 40:40-45.
96. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer 2006, 118:3030-3044.
97. Pepin A.C., Tandon R., Cattori V., Niederer E., Riond B.A., Willi B., Lutz H., Hofmann-Lehmann R. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats. Virus Research 2007, 127:9-16.
98. Pinches M.D.G., Helps C.R., Gruffydd-Jones T.J., Egan K., Jarrett O., Tasker S. Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. Journal of Feline Medicine and Surgery 2007, 9:8-13.
99. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of Type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous lymphoma. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences 1980, 77:7415-7419.
100. Poli A., Abramo F., Baldinotti F., Pistello M., Da Prato L., Bendinelli M. Malignant lymphoma associated with experimentally induced feline immunodeficiency virus infection. Journal of Comparative Pathology 1994, 110:319-328.
101. Poulet H., Brunet S., Boularand C., Guiot A.L., Leroy V., Tartaglia J., Minke J., Audonnet J.C., Desmettre P. Efficacy of a canarypox virus-vectored vaccine against feline leukaemia. Veterinary Record 2003, 153:141-145.
102. Povey R.C. A review of feline viral-rhinotracheitis (feline herpesvirus-1 infection). Comparative Immunology, Microbiology and Infectious Diseases 1979, 2:373-387.
103. Priester W.A., Mantel N. Occurrence of tumors in domestic animals. Data from 12 United States and Canadian Colleges of Veterinary Medicine. Journal of the National Cancer Institute 1971, 47:1333-1345.
104. Raphael M., Said J., Borisch B., Cesarman E., Harris N.L. Lymphomas associated with HIV infection. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, WHO Press, Geneva. S. Swerdllow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
105. Ravi M., Wobeser G.A., Taylor S.M., Jackson M.L. Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis. Canadian Veterinary Journal 2010, 51:271-276.
106. Reinacher M. Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats. Veterinary Immunology and Immunopathology 1989, 21:85-95.
107. Rezanka L.J., Rojko J.L., Neil J.C. Feline leukemia virus- pathogenesis of neoplastic disease. Cancer Investigation 1992, 10:371-389.
108. Rohn J.L., Overbaugh J. In vivo selection of long terminal repeat alterations in feline leukemia virus-induced thymic lymphomas. Virology 1995, 206:661-665.
109. Rohn J.L., Linenberger M.L., Hoover E.A., Overbaugh J. Evolution of feline leukemia virus variant genomes with insertions, deletions and defective envelope genes in infected cats with tumors. Journal of Virology 1994, 68:2458-2467.
110. Rojko J.L., Hoover E.A., Quackenbush S.L., Olsen R.G. Reactivation of feline leukemia virus infection. Nature 1982, 298:385-388.
111. Rojko J.L., Kociba G.J., Abkowitz J.L., Hamilton K.L., Hardy W.D., Ihle J.N., O'Brien S.J. Feline lymphomas - immunological and cytochemical characterization. Cancer Research 1989, 49:345-351.
112. Rous P. A sarcoma of the fowl transmissible by an agent from the tumor cells. Journal of Experimental Medicine 1911, 13:397-411.
113. Satou Y., Yasunaga J.-I., Zhao T., Yoshida M., Miyazato P., Takai K., Shimizu K., Ohshima K., Green P.L., Ohkura N., et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathogens 2011, 7:e1001274.
114. Schmiedt C.W., Grimes J.A., Holzman G., McAnulty J.F. Incidence and risk factors for development of malignant neoplasia after feline renal transplantation and cyclosporine-based immunosuppression. Veterinary and Comparative Oncology 2009, 7:45-53.
115. Schneide R., Frye F.L., Taylor D.O.N., Dorn C.R. A household cluster of malignant lymphoma. Cancer Research 1967, 27:1316-1322.
116. Sheets R., Pandey R., Jen W., Roy-Burman P. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. Journal of Virology 1993, 67:3118-3125.
117. Sheil A.G.R., Disney A.P.S., Mathew T.H., Livingston B.E.R., Keogh A.M. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplantation Proceedings 1997, 29:825-827.
118. Shelton G.H., Grant C.K., Cotter S.M., Gardner M.B., Hardy W.D., Digiacomo R.F. Feline immunodeficiency virus and feline leukemia-virus infections and their relationships to lymphoid malignancies in cats - a retrospective study (1968-1988). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1990, 3:623-630.
119. Shiramizu B., Herndier B.G., McGrath M.S. Identification of a common clonal human-immunodeficiency-virus integration site in human immunodeficiency virus-associated lymphomas. Cancer Research 1994, 54:2069-2072.
120. Spodnick G.J., Berg J., Moore F.M., Cotter S.M. Spinal lymphoma in cats - 21 cases (1976-1989). Journal of the American Veterinary Medical Association 1992, 200:373-376.
121. Stutzer B., Muller F., Majzoub M., Lutz H., Greene C.E., Hermanns W., Hartmann K. Role of latent feline leukemia virus infection in nonregenerative cytopenias of cats. Journal of Veterinary Internal Medicine 2010, 24:192-197.
122. Stutzer B., Simon K., Lutz H., Majzoub M., Hermanns W., Hirschberger J., Sauter-Louis C., Hartmann K. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma. Journal of Feline Medicine and Surgery 2011, 13:81-87.
123. Suntz M., Failing K., Hecht W., Schwartz D., Reinacher M. High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings. Veterinary Immunology and Immunopathology 2010, 136:71-80.
124. Svarovskaia E.S., Cheslock S.R., Zhang W.H., Hu W.S., Pathak V.K. Retroviral mutation rates and reverse transcriptase fidelity. Frontiers in Bioscience: A Journal and Virtual Library 2003, 8:d117-d134.
125. Tabrizi S.N., Brotherton J.M.L., Kaldor J.M., Skinner S.R., Cummins E., Liu B., Bateson D., McNamee K., Garefalakis M., Garland S.M. Fall in human papillomavirus prevalence following a national vaccination program. Journal of Infectious Diseases 2012, 206:1645-1651.
126. Terry A., Callanan J.J., Fulton R., Jarrett O., Neil J.C. Molecular analysis of tumours from feline immunodeficiency virus (FIV)-infected cats: An indirect role for FIV?. International Journal of Cancer 1995, 61:227-232.
127. Thun M.J., DeLancey J.O., Center M.M., Jemal A., Ward E.M. The global burden of cancer: Priorities for prevention. Carcinogenesis 2010, 31:100-110.
128. Torres A.N., Mathiason C.K., Hoover E.A. Re-examination of feline leukemia virus: Host relationships using real-time PCR. Virology 2005, 332:272-283.
129. Torres A.N., O'Halloran K.P., Larson L.J., Schultz R.D., Hoover E.A. Feline leukemia virus immunity induced by whole inactivated virus vaccination. Veterinary Immunology and Immunopathology 2010, 134:122-131.
130. Torten M., Franchini M., Barlough J., George J., Mozes E., Lutz H., Pedersen N. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. Journal of Virology 1991, 65:2225-2230.
131. Troyer R.M., Beatty J.A., Stutzman-Rodriguez K.R., Carver S., Lozano C.C., Lee J.S., Lappin M.R., Riley S.P.D., Serieys L.E.K., Logan K.A., et al. Novel gammaherpesviruses in North American domestic cats, bobcats and pumas: Identification, prevalence and risk factors. Journal of Virology 2014, 88:3914-3924.
132. Tsatsanis C., Fulton R., Nishigaki K., Tsujimoto H., Levy L., Terry A., Spandidos D., Onions D., Neil J.C. Genetic determinants of feline leukemia virus-induced lymphoid tumors: Patterns of proviral insertion and gene rearrengement. Journal of Virology 1994, 68:8296-8303.
133. Uren A., Kool J., Berns A., Van Lohuizen M. Retroviral insertional mutagenesis: Past, present and future. Oncogene 2005, 24:7656-7672.
134. Wang J., Kyaw-Tanner M., Lee C., Robinson W.F. Characterisation of lymphosarcomas in Australian cats using polymerase chain reaction and immunohistochemical examination. Australian Veterinary Journal 2001, 79:41-46.
135. Watanabe T., Seiki M., Yoshida M. HTLV Type-1 (United States isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virology 1984, 133:238-241.
136. Weijer K., Uijtdehaag F., Osterhaus A. Control of feline leukemia virus infection by a removal program. Veterinary Record 1986, 119:555-556.
137. Weiss A.T.A., Klopfleisch R., Gruber A.D. Prevalence of feline leukaemia provirus DNA in feline lymphomas. Journal of Feline Medicine and Surgery 2010, 12:929-935.
138. Wooldridge J.D., Gregory C.R., Mathews K.G., Aronson L.R., Kyles A.E. The prevalence of malignant neoplasia in feline renal-transplant recipients. Veterinary Surgery 2002, 31:94-97.
139. Yamamoto J., Hansen H., Ho E., Morishita T., Okuda T., Sawa T., Nakamura R., Pedersen N. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. Journal of the American Veterinary Medical Association 1989, 194:213-220.
140. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterisation of retrovirus from cell-lines of human adult T-cell leukemia and its implications in the disease. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences 1982, 79:2031-2035.
141. Young L.S., Murray P.G. Epstein-Barr virus and oncogenesis: From latent genes to tumours. Oncogene 2003, 22:5108-5121.